PharmEasy
Edit

PharmEasy

https://www.pharmeasy.in/
Last activity: 08.09.2025
Active
Categories: DiagnosticsDrugHealthTechInformationITLocalMedTechOnlineProductService
PharmEasy is one of India’s leading healthcare aggregators and most trusted medicine delivery app - Android /iOS. We help patients connect with local pharmacy stores and diagnostic centers in order to fulfill their extensive medical needs. Our aim is to revolutionize and improve the entire supply chain in the pharma sector by completely digitizing the process.

How do we do that?

- Make the industry data driven by providing doctors and patients the most accurate information to make informed decisions
- Make healthcare a universal right by making it quantum's cheaper and accessible
- Construct a feedback loop for pharma companies enabling them to make better medicines to combat diseases like never before
- Eradicate fake medicines which contribute to 30% of drug volume in
India

We’ve tied up with hundreds of offline retailers and authorized phlebotomist to make all genuine medicines available to you, as well as quality diagnostics services.

What makes us stand out from our competitors is we offer FLAT 20% OFF on every medicine order and UP TO 75% discounts on diagnostics tests.

Our persistent efforts have helped us to competently serve over 2 lakh families across India. We’ve touched more than 5 lakh lives and helped them save over INR 20 crores on medical expenses.

Currently, we serve customers in Mumbai, Thane, Navi Mumbai, Pune, Ahmedabad, Jaipur, Delhi, Noida, Gurugram, Kolkata and Bengaluru.

Going further, we aim to expand our geographical presence and penetrate further into existing markets to strengthen our category-leadership position.

For the latest updates, follow us on LinkedIn, Twitter and Instagram.
Likes
111.41K
Followers
152.04K
Website visits
17.4M /mo.
Mentions
154
Location: India, Maharashtra, Mumbai
Employees: 1001-5000
Total raised: $2.24B
Valuation: $5B
Founded date: 2015

Investors 11

Show more

Funding Rounds 10

DateSeriesAmountInvestors
04.05.2024-$316M-
23.08.2023-$423.05K-
10.11.2021IPO$842M-
20.10.2021Pre-IPO$350M-
25.06.2021Series C$200MBessemer V...
15.04.2021Series E$350MProsus
29.09.2018Series C$50MEight Road...
26.04.2017Series B$18MBessemer V...
03.04.2017Series B$17M-
-Series D$100M-

Mentions in press and media 154

DateTitleDescription
08.09.2025CVCs Gain Ground in India with Advantage in Long-Term View for Deeptech In 2024, Bain & Company's India Venture Capital Report finds that CVCs stepped up meaningfully: their deal volumes increased...Corporate Venture Capital (CVC) firms have a disproportionate advantage over traditional VC firms, especially in areas such as deeptech, in terms of long-term mapping, said Adarsh Sekhar, Partner, IBM Ventures. In 2021, IBM committed USD 1 ...
05.09.2025The Future of Generic Medicine Retail in IndiaAhmedabad, Gujarat, India India’s pharmacy and healthcare sector has emerged as one of the most dynamic industries in the world, driven by a growing population, increasing healthcare needs, and rising demand for affordable medicines. With a...
03.09.2025Online pharmacy PlatinumRx raises $6 million in round led by Stellaris Venture PartnersSynopsis Existing investor India Quotient participated in the funding round. The platform, which helps customers find substitute brands of affordable drugs, plans to use the fresh capital to expand operations, add new fulfilment centres and...
01.09.2025India's Tech Surge: Elev8 Closes $160M Fund, Fuels Next-Gen StartupsElev8 Venture Partners concluded its landmark $160 million maiden fund for India's surging tech landscape. The growth-stage vehicle targets high-potential startups in fintech, SaaS, B2B platforms, and consumer brands. Anchor investors inclu...
01.09.2025Elev8 Venture Partners marks $160 million close of maiden fundSynopsis The fund counts institutions from South Korea, Hong Kong and India among its backers, alongside sovereign funds, family offices and several unicorn founders. South Korea-based KB Investment is the anchor limited partner, while Self...
19.08.2025W Health Ventures Strengthens Leadership Team with Four Senior Appointments Ashish Singh, Dr. Prakash Patel, and Ajay Sondhi have joined as Operating Partners, while Mahadevan "Mahad" Naraya...W Health Ventures has announced the appointment of four senior leaders to its leadership team as it continues to expand its healthcare-focused company creation model. Ashish Singh, Dr. Prakash Patel, and Ajay Sondhi have joined as Operating...
19.08.2025Healthcare-focused VC W Health Ventures makes four leadership appointmentsCredit: 123RF.com Healthcare-focused venture capital firm W Health Ventures, which rolled out its second flagship fund last month targeting to raise $100 million (around Rs 870 crore), has added four industry leaders to its team as it doubl...
11.08.2025Truemeds Secures $85 Million to Revolutionize India's Healthcare AccessTruemeds, a leading e-pharmacy, secured $85 million in Series C funding. Accel and Peak XV Partners led the investment. This significant capital injection accelerates its mission. The company targets India's vast non-metro regions. It deliv...
11.08.2025Truemeds closes $85 million funding led by Accel and Peak XV PartnersSynopsis Truemeds, a telehealth platform, has received $85 million in funding. Accel and Peak XV Partners led the investment round. The company plans to expand its fulfillment centers and team. They will also establish a technology hub in B...
11.08.2025Truemeds raises $85M to target non-metro marketsEpharmacy and telehealth platform Truemeds has raised $85 million in Series C funding to accelerate its push into smaller cities and towns. The financing, completed in two tranches, was led first by Accel and later by Peak XV Partners, with...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In